1/60
Looks like no tags are added yet.
what determines a person’s blood group
presence or absence of specific antigens on the surface of red blood cells
what are red blood cell antigens
specific molecules (including glycoproteins and glycolipids) on the red blood cell surface that can trigger an immune response if introduced into someone who does not have them
why are red blood cell antigens important
they determine blood groups and are important for blood transfusion compatibility because they can trigger an immune response
what are antibodies
proteins produced by the immune system that recognise and bind to specific antigens
what happens when an antibody recognises a foreign red blood cell antigen
the antibody binds to the antigen, potentially triggering an immune response and destruction of the red blood cells
what are the two main blood group systems
ABO blood group system and Rhesus (RhD) blood group system
what are the four blood group phenotypes in the ABO system
A, B, AB, O
what determines a person’s ABO blood group
the presence or absence of A and B glycolipid antigens on the surface of red blood cells
how many genes control the ABO blood group system
one gene with three possible alleles: Iᴬ, Iᴮ, i
which antigens are present on RBCs in blood group A
A antigens only
which antigens are present on RBCs in blood group B
B antigens only
which antigens are present on RBCs in blood group AB
both A and B antigens
which antigens are present on RBCs in blood group O
neither A or B antigens
which antibodies are naturally present in the plasma of someone with blood group A
anti-B antibodies
which antibodies are naturally present in the plasma of someone with blood group B
anti-A antibodies
which antibodies are naturally present in the plasma of someone with blood group AB
neither anti-A or anti-B antibodies
which antibodies are naturally present in the plasma of someone with blood group O
both anti-A and anti-B antibodies
why do people naturally produce antibodies against certain ABO antigens
they produce antibodies against the ABO antigens they do not have, even without prior exposure (e.g. blood transfusion or pregnancy)
what are naturally occurring ABO antibodies
antibodies present without prior exposure to foreign red blood cells, e.g. through transfusion or pregnancy
what type of antibodies are naturally occurring ABO antibodies
mainly Immunoglobulin M (IgM) - largest type of antibody the immune system produces
what may trigger the production of naturally occurring ABO antibodies
exposure to similar antigens found in food or gut - unusual and unique situation in immunology
what is the relationship between ABO antigens and antibodies
people have antibodies against the ABO antigens they do not possess
which blood group is known as the universal recipient for RBC transfusions and why
blood group AB - people with this blood group have no anti-A or anti-B antibodies in their plasma so A or B donor RBCs won’t be attacked by these
which blood group is known as the universal donor for RBC transfusions and why
blood group O - group O RBCs have neither A or B antigens making them less likely to be attacked by the recipient’s anti-A or anti-B antibodies
what is the Rh blood group
a blood group system determined by the presence or absence of specific antigens on RBCs, particularly the RhD antigen
what determines whether someone is RhD positive or RhD negative
RhD positive - D antigen is present on RBCs; RhD negative - D antigen is absent from RBCs
what happens when an RhD-negative person is exposed to RhD-positive RBCs
their immune system may recognise the D antigen as foreign and produce ant-D antibodies
what is sensitisation in the RhD blood group system
when an RhD-negative person’s immune system is exposed to RhD positive blood and begins producing anti-D antibodies
how can an RhD-negative person become sensitised
through exposure to RhD-positive red blood cells, e.g. blood transfusion or pregnancy
how do anti-D antibodies differ from ABO antibodies
ABO antibodies are naturally occurring and are mostly IgM whereas anti-D antibodies are not naturally present and develop following exposure to RhD-positive RBCs
what type of antibody is anti-D
Immunoglobulin G (IgG)
why are anti-D IgG antibodies particularly important during pregnancy
IgG antibodies can cross the placenta and attack the red blood cells of an RhD-positive fetus
what complications can anti-D antibodies cause
haemolytic transfusion reactions and haemolytic disease of the fetus and newbor (HDFN)
why is blood group compatibility essential before a blood transfusion
to prevent the recipient’s antibodies from recognising and attacking donor red blood cell antigens, which can cause a serious or fatal immune reaction
what type of hypersensitivity reaction can occur following an incompatible blood transfusion
Type II hypersensitivity (cytotoxic antibody-dependent destruction of donor red blood cells)
what happens during an incompatible blood transfusion
the recipient’s antibodies recognise foreign antigens on donor red blood cells, bind to them and trigger their destruction (haemolysis)
what is a haemolytic transfusion reaction
an immune reaction in which antibodies attack and destroy transfused red blood cells
why can an incompatible blood transfusion be life-threatening
because antibody-mediated destruction of donor red blood cells can cause a serious transfusion reaction and potentially be fatal
why must both ABO and RhD be considered before transufsion
incompatibility involving either system can cause an immune response against donor RBCs
why is the term ‘universal donor’ not straightforward
other blood group antigens, including RhD, can also trigger immune reactions
why is transfusing whole blood more complicated than transfusing packed red blood cells
whole blood contains donor plasma and antibodies that could react with the recipient’s red blood cells
why are packed red blood cells commonly used instead of whole blood
they contain very little plasma, reducing the amount of donor antibodies introduced into the recipient’s circulation
why are any remaining donor antibodies in packed red blood cells less problematic
they are diluted in the recipient’s blood
why is matching blood groups important in clinical practice
to reduce the risk of immune reactions, haemolysis and potentially fatal transfusion complications
what is haemolytic disease of the fetus and newborn (HDFN)
a condition in which maternal antibodies cross the placenta and destroy the red blood cells of the fetus or newborn
how can RhF incompatibility cause HDFN
when an RhD-negative mother carries an RhD-positive baby, she may become sensitised to the baby’s D antigen and produce anti-D antibodies
what happens during the first pregnancy when an RhD-negative mother carries an RhD-positive baby
RhD-positive fetal RBCs may enter the mother’s circulation > the mother’s immune system may recognise the D antigen as foreign > she may become sensitised and produce anti-D antibodies
why is the first pregnancy usually not affected by RhD-related HDFN
sensitisation commonly occurs late in pregnancy or around delivery, so significant anti-D antibody production usually occurs after the first baby has been delivered
what happens during a subsequent pregnancy if an RhD-negative mother carries another RhD-positive baby
the mother’s anti-D IgG antibodies cross the placenta > they attach to the baby’s red blood cells > the baby’s red blood cells are destroyed through haemolysis
why can maternal anti-D antibodies cross the placenta
anti-D antibodies are IgG which are able to cross the placenta
what are the effects of HDFN on the baby
anaemia due to RBC destruction, jaundice due to increased bilirubin, sever illness, fetal death in sever cases
why does HDFN cause anaemia in the baby
maternal anti-D antibodies destroy the baby’s RBCs, reducing the number of circulating RBCs and haemoglobin
why can HDFN cause jaundice in the baby
the destruction of RBCs releases haemoglobin which is broken down into bilirubin > increased bilirubin causes jaundice
how can HDFN be treated in an affected newborn
phototherapy to reduce bilirubin; blood transfusions to treat significant anaemia; exchange transfusions in severe cases
what is the purpose of anti-D immunoglobulin injections during pregnancy
to prevent an RhD-negative mother from becoming sensitised to RhD-positive fetal RBCs
how does an anti-D immunoglobulin prevent sensitisation
it removes RhD-positive fetal RBCs from the mother’s circulation before her immune system can become sensitised and produce its own anti-D antibodies
when should an RhD-negative mother receive anti-D immunoglobulin
during pregnancy, after potentially sensitising events, after delivering an RhD-positive baby
how has anti-D immunoglobulin affected the incidence of RhD-related HDFN
it has made RhD-related HDFN much less common
why must a patient’s blood group be established before a blood transfusion
to identify their ABO and RhD blood groups and ensure compatible donor red blood cells are selected
what blood group information should be considered when selecting donor red blood cells
the recipient’s ABO and RhD blood groups, alongside other relevant blood group antigens
why is anti-D immunoglobulin preventative rather than a treatment for established sensitisation
it prevents the mother’s immune system from becoming sensitised rather than removing anti-D antibodies that her immune system has already produced